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Abstract
Background: Reverse transcription-polymerase chain reaction (RT-PCR) is the main method for
laboratory diagnosis of norovirus-associated infectious intestinal disease (IID). However, up to 16%
of healthy individuals in the community, with no recent history of IID, may be RT-PCR positive; so
it is unclear whether norovirus is actually the cause of illness in an IID case when they are RT-PCR
positive. It is important to identify the pathogen causing illness in sporadic IID cases, for clinical
management and for community based incidence studies. The aim of this study was to investigate
how faecal viral load can be used to determine when norovirus is the most likely cause of illness in
an IID case.
Methods: Real-time RT-PCR was used to determine the viral load in faecal specimens collected
from 589 IID cases and 159 healthy controls, who were infected with genogroup II noroviruses.
Cycle threshold (Ct) values from the real-time RT-PCR were used as a proxy measure of viral load.
Receiver-operating characteristic (ROC) analysis was used to identify a cut-off in viral load for
attributing illness to norovirus in IID cases.
Results: One hundred and sixty-nine IID cases and 159 controls met the inclusion criteria for the
ROC analysis. The optimal Ct value cut-off for attributing IID to norovirus was 31. The same cut-
off was selected when using healthy controls, or IID cases who were positive by culture for
bacterial pathogens, as the reference negative group. This alternative reference negative group can
be identified amongst specimens routinely received in clinical virology laboratories.
Conclusion: We demonstrated that ROC analysis can be used to select a cut-off for a norovirus
real time RT-PCR assay, to aid clinical interpretation and diagnose when norovirus is the cause of
IID. Specimens routinely received for diagnosis in clinical virology laboratories can be used to select
an appropriate cut-off. Individual laboratories can use this method to define in-house cut-offs for
their assays, to provide the best possible diagnostic service to clinicians and public health workers.
Other clinical and epidemiological information should also be considered for patients with Ct
values close to the cut-off, for the most accurate diagnosis of IID aetiology.
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Infectious intestinal disease (IID) is a syndrome of mixed
aetiology; many different pathogens can infect the human
gastrointestinal tract and produce diarrhoea, vomiting
and other characteristic symptoms. Mixed gastrointestinal
infections are frequently detected, especially in infants
and young children and when polymerase chain reaction
(PCR) assays are used for diagnosis [1,2]. It is important
to determine which pathogen is the cause of illness, in
order to direct clinical management for individual
patients and to advance epidemiological understanding
of IID.
Reverse transcription- PCR (RT-PCR) is now the method
of choice for detecting norovirus in clinical specimens.
RT-PCR detects norovirus at lower concentrations and is
less affected by specimen quality and preparation than
electron microscopy [3-5]; large numbers of specimens
can be tested simultaneously, compared to the single
throughput for electron microscopy. RT-PCR also detects
a much wider range of norovirus genetic variants than
enzyme-linked immunosorbent assays (ELISA) and may
be more easily adaptable for detection of new strains [6].
However, many healthy individuals, with no recent his-
tory of IID, are RT-PCR positive [7-9], meaning that virus
detection by RT-PCR is not well correlated with disease in
norovirus infection. If RT-PCR positivity does not neces-
sarily equate to norovirus-associated IID, it cannot be
used alone to attribute illness to norovirus in IID cases; it
is possible that the norovirus infection is 'asymptomatic'
in the IID case, with another pathogen, detected or unde-
tected, actually causing the symptoms. The poor diagnos-
tic specificity of PCR and the associated difficulties for
clinical interpretation of test results have been highlighted
for other viral pathogens [10,11].
Previous studies have demonstrated differences in faecal
norovirus load between symptomatically and asympto-
matically infected individuals [7,12]. Histopathological
investigations of experimentally inoculated volunteers
and naturally infected individuals also indicate that the
mechanism of pathogenesis in norovirus infection may
rely on damage to the intestinal epithelium, caused by
viral replication [13-15], so that symptoms may be a result
of high viral loads. The aim of this study was to use faecal
viral load measurements to determine when illness is
attributable to norovirus in IID cases.
Methods
Specimens
Faecal specimens were collected from IID cases and
healthy controls during the Infectious Intestinal Disease
Study for England (1993–1996) [16]. IID cases were
recruited from a prospectively followed cohort in the
community, or on consultation with their general practi-
tioner for IID. IID cases had acute diarrhoea or vomiting,
lasting less than two weeks, with no known non-infec-
tious cause, preceded by a symptom free period of at least
three weeks [17]. Healthy controls, with no history of IID
for the preceding three weeks, were recruited from within
the community cohort or from the registration lists of par-
ticipating general practices (but not after consultation for
another condition) [17]. Controls were recruited concur-
rently to IID cases. IID cases were asked to provide a faecal
specimen during acute illness and controls provided a
specimen at recruitment.
Testing
In the original study, norovirus was detected using elec-
tron microscopy. Faecal specimens were also tested for a
range of other bacterial, viral and protozoal pathogens,
using bacterial culture, microscopy or ELISA. Specimens
with sufficient volume remaining after testing were
archived in frozen storage [18]. Subsequently the archived
specimens were all re-tested for norovirus using RT-PCR
[7,19]. PCR testing was also used to detect seven other
common bacterial, viral and protozoal pathogens.
For the present study, norovirus RNA was re-extracted
from the stored faecal specimens that were previously pos-
itive for norovirus by EM or RT-PCR, and real-time RT-
PCR (method previously described [7]) was used to deter-
mine the viral load. The real time RT-PCR assay has sepa-
rate primer pairs for norovirus genogroup I and
genogroup II, so it was possible to use the assay to identify
the genogroup of norovirus present. Only viral load meas-
urements from norovirus genogroup II positive specimens
were used for this analysis; differences in the performance
of the two genogroup specific assays mean that it is not
appropriate to directly compare the results between the
two genogroups (J. Gray, personal communication). Spec-
imen collection and testing for norovirus is summarised
in Additional File 1.
Data
The cycle threshold (Ct) value from the real time RT-PCR
was used as a proxy measure of faecal viral load. The Ct
value is inversely proportional to the amount of virus
present in the specimen, so the lower the Ct value the
higher the faecal viral load. The Ct value represents the
number of rounds of PCR replication required to raise the
number of copies of the target sequence in the reaction
mixture above a pre-determined threshold [20]. The real
time RT-PCR assay was run for 40 cycles, so the maximum
possible Ct value for positive specimens in this study was
39.
Descriptive analysis
The median Ct value and inter-quartile range were calcu-
lated for IID cases and controls; comparisons were made
between groups using the rank-sum test in Stata 10 [21].Page 2 of 9
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Receiver-operating characteristic (ROC) analysis was used
to define a cut-off in the Ct values, to attribute disease to
norovirus in IID cases. There is no gold standard test for
diagnosing norovirus-associated IID. We therefore used
microbiological and clinical characteristics to select refer-
ence groups for the ROC analysis.
Reference positive groups
We defined three reference positive groups, selected to
have Ct values that are representative of where norovirus
is causing illness (Table 1). Reference positive group 1
included only IID cases who were diagnosed as norovirus
positive by electron microscopy; the high viral loads
required for detection by electron microscopy correspond
to viral shedding during acute infection in experimentally
inoculated volunteers [22,23], so these IID cases are
highly likely to have IID caused by norovirus.
In reference positive group 2, we additionally included
IID cases who were electron microscopy negative and sub-
sequently RT-PCR positive, providing that they had no
other pathogens identified in their stool and that they had
collected a specimen early in their illness (less than three
days since symptom onset). These two restrictions were
used to ensure that norovirus was the most likely cause of
their illness and to ensure that their faecal viral load is rep-
resentative of acute symptomatic norovirus infection
[12,22,23]. We defined this second reference group to
determine whether using only electron microscopy posi-
tive cases in reference group 1 biased the cut-off to lower
Ct values (higher viral loads).
Reference positive group 3 included IID cases who were
RT-PCR positive for norovirus (including those previously
positive by EM) and who were negative for other bacterial,
protozoal and viral pathogens that are routinely detected
in clinical diagnostic algorithms for sporadic IID in
National Health Service laboratories in the UK [24,25].
This restriction was used to make norovirus the most
likely cause of illness in these IID cases, so that their Ct
values should be representative of where norovirus is
causing illness. We defined this third reference positive
group to explore whether it is suitable for selecting a Ct
value cut-off, because electron microscopy diagnosis is no
longer used in clinical laboratories in the UK, so cannot be
used to select a reference positive group in future studies.
Reference negative groups
We defined two reference negative groups, selected to
have Ct values representative of where norovirus is not
causing illness (Table 1). Reference negative group 1
included norovirus-infected healthy controls. Reference
negative group 2 included norovirus infected IID cases
Table 1: Inclusion criteria for the ROC analysis reference groups
Reference group Inclusion Criteria
Reference 
positive 1
1. IID
2. Norovirus detected by electron microscopy
3. Norovirus infection confirmed by RT-PCR
Reference 
positive 2
1. IID
2. Norovirus detected by electron microscopy
3. Norovirus infection confirmed by RT-PCR
Or
1. IID
2. Electron microscopy negative
3. Norovirus detected by RT-PCR
4. No other pathogen detected
5. Specimen collected within 3 days of symptom onset
Reference 
positive 3
1. IID
2. Norovirus detected by electron microscopy and/or RT-PCR
3. Negative for Campylobacter spp., Salmonella spp. and Shigella spp. by bacterial culture and Cryptosporidium spp. by light 
microscopy 
(and rotavirus A by ELISA in children aged less than five years only)
Reference 
negative 1
1. No history of IID in previous 3 weeks
2. Norovirus detected by RT-PCR
Reference 
negative 2
1. IID
2. Norovirus detected by RT-PCR
3. Infection with Salmonella spp., Campylobacter spp. or Shigella spp. detected by bacterial culture or Cryptosporidium spp. detected 
by light microscopy
(or rotavirus A by ELISA in children aged less than five years only)Page 3 of 9
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rus A infection diagnosed by ELISA (for children aged less
than five years only). Bacterial culture without enrich-
ment may indicate the presence of high concentrations of
viable bacterial cells, meaning that the bacteria detected
are likely to be causing illness, rather than the norovirus
infection. Similarly, ELISA for rotavirus A has a high detec-
tion limit that correlates well with disease [26,27], so rota-
virus A is probably the cause of illness in ELISA positive
individuals, rather than the norovirus infection. We
defined this second reference negative group to explore
whether it is suitable for selecting a cut-off, because spec-
imens from healthy controls are not routinely received in
clinical laboratories, so cannot be used as the reference
negative group if other laboratories want to use this
method to develop a cut-off for their real time assays.
In each ROC analysis, the sensitivity and specificity were
calculated for each potential cut-off in the range of Ct val-
ues and an empirical ROC plot created using Stata 10 [21].
The Youden index (sensitivity + specificity-1) was calcu-
lated and the maximum value used to identify the optimal
cut-off [28-30]. The analysis was done for all ages together
and then separately, in children aged less than five years
and individuals aged five years or older.
Ethics
Ethical approval was granted from both local and national
research ethics committees (Royal College of General
Practitioners, London School of Hygiene and Tropical
Medicine, Public Health Laboratory Service) for the IID
study, including creation of the faecal specimen archive
[17]. Written, informed consent was obtained from all
cases and controls. The faecal specimen archive was ano-
nymised and no further ethical approval was sought for
the retesting in this study.
Results
Descriptive analysis
Ct values were generated for 589 IID cases and 159
healthy controls, who were infected with genogroup II
noroviruses; 92 of the IID cases were positive by electron
microscopy and 497 were negative by electron micros-
copy but subsequently positive by RT-PCR. IID cases were
aged up to 94 years and controls up to 84 years; 40% of
IID cases and 60% of controls were aged less than five
years.
The median Ct value was lower in IID cases (median 34)
than in controls (median 38) (Table 2). The difference
compared to controls was greatest for IID cases positive by
electron microscopy (median 24); there was very little
overlap in the distribution of Ct values in electron micro-
scopy positive IID cases and controls (Figure 1). The dis-
tribution of Ct values for the IID cases who were negative
by electron microscopy and subsequently RT-PCR positive
overlaps substantially with the controls, although a small
proportion have the higher viral loads seen in the electron
microscopy positive IID cases (Figure 1, Table 2).
ROC analysis
The numbers of specimens meeting the inclusion criteria
for each of the reference groups are shown in Table 3.
The optimal cut-off for attributing illness to genogroup II
noroviruses in IID cases was at Ct value 31, corresponding
to the maximum Youden index for the ROC analysis with
reference positive group 1 and reference negative group 1
(Figure 2).
Using this cut-off, IID cases with Ct values of 31 or below
are classified as 'positive' for norovirus-associated IID:
they have disease caused by norovirus. IID cases with Ct
values above 31 are classified as 'negative' for norovirus-
associated IID: they have disease but their norovirus infec-
tion was not the cause of their symptoms.
The optimal cut-off for children aged less than five years
was at Ct value 30, whereas for older children and adults
it was at Ct value 33 (Table 3). There was some evidence
of a difference in Ct value distribution between electron
microscopy positive IID cases in these two age groups
(rank sum test p = 0.036), with the median in children
aged less than five years at Ct value 23 and at Ct value 25
Percentage distribution of real time RT-PCR Ct values in IID cases and controlsFigure 1
Percentage distribution of real time RT-PCR Ct val-
ues in IID cases and controls. Low Ct values correspond 
to high viral loads; the viral load decreases with increasing Ct 
value. 'EM cases' are IID cases positive by electron micros-
copy, 'RT-PCR cases' are IID cases negative by electron 
microscopy and subsequently positive by RT-PCR. Sample 
sizes: EM cases = 92, RT-PCR cases = 497, controls = 159.
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the different cut-offs may reflect a true difference in viral
load between these age groups.
The optimal cut-off (all ages) was also at Ct value 31 when
RT-PCR positive cases with no other pathogen detected
and early specimen collection were included in the refer-
ence positive group (reference positive group 2) (Table 3).
This was also true for the age-group specific ROC analyses
(data not shown). The optimal cut-off was also at Ct value
31 when norovirus positive IID cases who were negative
for other commonly tested enteric pathogens were used as
Table 2: Ct values in genogroup II norovirus positive IID cases and healthy controls. 
Method of norovirus detection IID Cases Controls Rank-sum test p-value
comparing cases to controls
Median Ct
value
Ct value
IQR
Sample
size
Median Ct
value
Ct value
IQR
Sample
size
All ages
All 34 25–37 589 38 35–39 159 <0.0001
Electron microscopy 24 21–27.5 92 <0.0001
RT-PCR
(Electron microscopy negative)
35 29–38 497 <0.0001
< 5 years
All 34 26–37 253 37 34–38 92 <0.0001
Electron microscopy 23 21–25 48 <0.0001
RT-PCR
(Electron microscopy negative)
35 32–37 205 0.0001
5 years +
All 34 25–38 334 38 36–39 67 <0.0001
Electron microscopy 25 22–28.5 44 <0.0001
RT-PCR
(Electron microscopy negative)
35 27–38 290 <0.0001
The rank-sum tests for electron microscopy and RT-PCR positive IID cases compare them to all controls. Age was not recorded for two IID cases. 
IQR is the interquartile range.
Table 3: ROC analysis results. 
Reference groups used Optimal Ct cut-off Youden Index Sensitivity
(95% CI)
Specificity
(95% CI)
AUC Sample size
Reference positive Reference negative
Ref positive 1
Ref negative 1
All 31 0.77 0.88
(0.65–1.00)
0.89
(0.84–0.94)
0.93 92 159
aged <5 years 30 0.80 0.94
(0.84–1.00)
0.86
(0.79–0.93)
0.93 48 92
aged >5 years 33 0.83 0.89
(0.79–0.98)
0.94
(0.88–1.00)
0.96 44 67
Ref positive 2
Ref negative 1
31 0.61 0.72
(0.66–0.79)
0.89
(0.84–0.94)
0.87 169 159
Ref positive 3
Ref negative 2
31 0.29 0.43
(0.39–0.47)
0.86
(0.77–0.94)
0.64 524 64
The reference groups are described in Table 1. AUC is the area under the curve.Page 5 of 9
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and the bacterial culture positive IID cases were used as
the reference negative group (reference negative group 2).
The Ct values discriminated well between reference posi-
tive group 1 and reference negative group 1, because the
area under the ROC curve was close to the maximum
value of one (Figure 3, Table 3). The discriminatory power
of the Ct values was poorer for the ROC analysis when RT-
PCR positive cases with no other pathogen detected and
early specimen collection were included in the reference
positive group (reference positive group 2). The discrimi-
natory power was very low for distinguishing between ref-
erence positive group 3 and reference negative group 2
because the area under the curve was close to 0.5, which is
indicative of a test with no discriminatory power.
Discussion
In this study we have demonstrated a difference in viral
load between symptomatic and asymptomatic norovirus
infection. A substantial proportion of IID cases who were
positive only by RT-PCR had viral loads equivalent to
those in healthy controls. This supports the hypothesis
that norovirus is not always the cause of illness where it is
detected by RT-PCR. We have shown that it is possible to
use the viral load in clinical specimens to indicate where
norovirus is the most likely cause of illness, by selecting a
cut-off for the norovirus real time RT-PCR assay. We have
also shown that the method of cut-off selection can be
adapted for use with specimens that are routinely received
and tested in clinical laboratories, to help other laborato-
ries develop in-house cut-offs for their assays. This is
essential because there is substantial variability between
UK virology reference laboratories in the Ct values pro-
duced from standard reference specimens [31]; the same
cut-off may not be appropriate for all laboratories because
of these differences in assay performance.
A major strength of this study is the availability of speci-
mens from healthy controls. There are few community
studies of IID with large control groups available, but they
are essential for interpreting the RT-PCR data in IID cases.
Importantly, it has been possible to validate the use of
bacterial culture positive IID cases as a reference negative
group, by comparison to the ROC analysis using healthy
controls; this removes the need to collect further control
specimens in future studies. We have also shown that RT-
PCR positive IID cases, who are negative for other com-
mon bacterial, protozoal and viral pathogens, are a suita-
ble reference positive group, so that the method can be
used by laboratories without EM testing facilities. These
reference groups can now be used by other laboratories
for development of cut-offs for their assays.
The area under the ROC curve for the alternative reference
groups is very low, possibly because the viral loads in
many of the IID cases in the reference positive group were
not representative of symptomatic norovirus infection;
this is reflected in the low sensitivity for the cut-off at Ct
value 31 when using these groups in the ROC analysis.
However, selection of an appropriate cut-off is the main
aim of this method and we have shown that this is possi-
Youden Index from ROC analysis for reference positive group 1 and re erence neg tive group 1Fig re 2
Youden Index from ROC analysis for reference posi-
tive group 1 and reference negative group 1. Refer-
ence positive group 1 were electron microscopy positive IID 
cases and reference negative group 1 were RT-PCR positive 
healthy controls.
ROC plot for reference positive group 1 and reference nega-tive group 1Figure 3
ROC plot for reference positive group 1 and refer-
ence negative group 1. Reference positive group 1 were 
electron microscopy positive IID cases and reference nega-
tive group 1 were RT-PCR positive healthy controls. The 
diagonal line represents a ROC plot for a test with no dis-
criminatory power.
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the diagnostic performance (sensitivity, specificity, pre-
dictive values) of the cut-off is determined using an inde-
pendent dataset, which was not possible in this study; the
sensitivity and specificity calculated in the ROC analysis
may misrepresent the performance of the cut-off in clini-
cal application, because the cut-off is selected by optimis-
ing the diagnostic accuracy compared to the gold standard
[32,33].
The specimens used in this study were originally collected
during the mid 1990s and the viral RNA may have
degraded during the prolonged storage and repeated
freeze-thaw cycles for re-testing. Therefore the cut-off
developed here should not be directly applicable to real-
time RT-PCR results from fresh specimens without valida-
tion. Similarly, the cut-off should not be applied to assays
with different protocols, because the Ct values may not
equate to the same viral load per gram of faeces. It is
unlikely, however, that there will have been differential
degradation of RNA between specimens during storage, so
it is still valid to compare the viral load between speci-
mens in this collection, and to assume that the relative dif-
ferences observed between IID cases and controls are a
true reflection of symptomatic and asymptomatic infec-
tion. It is also important to note that any cut-off in viral
load can only be applied to specimens collected from IID
patients during acute symptoms, when the viral load is
representative of disease aetiology. After symptoms
resolve in norovirus-associated IID, the viral load quickly
drops to levels seen in asymptomatic infection [12] and
the predictive value of the cut-off will be greatly reduced.
The cut-off developed here is not applicable to two of the
rarer genotypes in genogroup II (GII-7 and GII-8),
because the real time RT-PCR assay has poorer efficiency
(a higher detection limit) for these genotypes (J. Gray, per-
sonal communication), so the Ct values do not represent
the same faecal viral loads as for the other genotypes. At a
population level, the degree of misclassification would be
small because of the low prevalence of GII-7 and GII-8
[34-36]. However, correct identification of illness caused
by these genotypes may be important for clinical manage-
ment, but would require development of genotype-spe-
cific cut-offs. Similarly, we have excluded genogroup I
noroviruses from this analysis because the efficiency of
the assay is highly variable for genotypes within in this
genogroup. Development of a cut-off for GII-7 and GII-8
or genogroup I noroviruses would require collection of
sufficient specimens for genotype-specific ROC analyses;
clinical application would require genotyping to be part
of routine diagnosis, which may not be economically or
logistically feasible. Further work is also needed to charac-
terise the kinetics of the real time RT-PCR assay, to deter-
mine whether a Ct value of 31 translates to the same faecal
viral load for all genogroup II genotypes with the same
assay efficiency. Selection of a single cut-off may also not
be appropriate if the Youden index is similar for a range of
Ct values between 28 and 33, as was the case in this anal-
ysis. With a larger sample size, in future studies, there may
be better power to discriminate between potential cut-offs
in this range. Nevertheless, the cut-off provides a major
improvement in diagnostic specificity compared to the
current qualitative use of RT-PCR in norovirus diagnosis.
The causal relationship between disease symptoms and
viral load has not been established. However, if the rela-
tionship between the occurrence of disease and viral load
is consistent, regardless of whether high viral loads are a
cause or a consequence of disease, viral load will be a
good marker of norovirus-associated IID and the
approach developed here is valid. Viral load is routinely
used to predict outcome and guide clinical management
for a number of viruses that cause chronic infections, such
as Epstein-Barr virus [37] and cytomegalovirus [38] in
transplant patients, HIV [39], hepatitis C [40] and HTLV
[41]. However this is the first time, to our knowledge, that
viral load has been used as a tool for diagnosing enteric
viruses as the cause of acute IID.
Conclusion
As PCR diagnosis is applied to an increasing number of
viral pathogens, the debate is growing about the clinical
interpretation of positive results and the utility of PCR in
diagnostic services [10,42,43]. PCR has many advantages
over traditional diagnostic methods, including higher
throughput, shorter turnaround time, adaptability to new
strains and production of data for molecular epidemio-
logical surveillance. It is therefore important to ensure
that clinically informative results are produced from PCR
assays, to provide a high standard of patient care along-
side these other benefits. The method developed here
shows that the real-time RT-PCR output for norovirus can
be used to attribute disease to norovirus in IID cases,
where simple detection may not be sufficient to give a
confident diagnosis of norovirus-associated IID. This
semi-quantitative approach to diagnosis can improve
both the accuracy of community-based estimates of noro-
virus associated IID incidence and the interpretability of
diagnostic results provided to clinicians from clinical
virology laboratories. However it is important that clinical
and epidemiological information is considered in the
diagnosis of disease aetiology for individual patients with
Ct values close to the cut-off.
Independent validation of this method is required prior to
application in other studies and laboratories; we have pro-
vided a method for validation without the need for collec-
tion of specimens from healthy controls or further use of
EM. The method may also be useful for other viral patho-Page 7 of 9
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ity of PCR have been described. Future work will focus on
applying this approach for estimation of norovirus associ-
ated IID incidence and describing the implications for
diagnosis of norovirus outbreaks.
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